Kina Chan
Adult Health · Brooklyn, NYNPI 1609577618
Payments from drug & device makers
Across 99 payments — averaging $31.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$546
- AstraZeneca$392
- Merck$355
- Eisai Inc.$264
- Lilly USA, LLC$222
- Novartis$165
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,87391%
- Education$2769%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $546 |
| AstraZeneca | 10 | $392 |
| Merck | 10 | $355 |
| Eisai Inc. | 11 | $264 |
| Lilly USA, LLC | 3 | $222 |
| Novartis | 8 | $165 |
| Regeneron Healthcare Solutions, Inc. | 2 | $152 |
| Stemline Therapeutics Inc. | 4 | $93 |
| Taiho Oncology, Inc. | 4 | $91 |
| Puma Biotechnology, Inc. | 4 | $83 |
| Pfizer | 3 | $71 |
| Astellas Pharma US Inc | 1 | $70 |
| Daiichi Sankyo Inc. | 3 | $69 |
| Incyte Corporation | 3 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| EMD Serono, Inc. | 2 | $57 |
| Array Biopharma Inc | 2 | $45 |
| Recordati_rare_diseases_inc. | 1 | $34 |
| GE HealthCare | 1 | $31 |
| Beone Medicines USA, Inc. | 1 | $30 |
| Gilead | 1 | $29 |
| Bayer | 1 | $26 |
| Beigene USA, Inc. | 1 | $26 |
| Shield Therapeutics Inc | 1 | $25 |
| Immunocore Limited | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Mirati Therapeutics, Inc. | 1 | $21 |
| Sobi, Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,148 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TagrissoOsimertinib Mesylate | 103 | $1,713,525 |
| OpdivoNivolumab | 27 | $206,094 |
| KeytrudaPembrolizumab | 20 | $191,015 |
| ProcritEpoetin Alfa | 28 | $115,679 |
| TruximaRituximab-Abbs | 12 | $74,122 |
| Pemetrexed Disodium | 13 | $32,904 |
| RetacritEpoetin Alfa-Epbx | 17 | $29,762 |
| NivestymFilgrastim-Aafi | 14 | $28,654 |
| Abiraterone Acetate | 12 | $10,620 |
| Palonosetron Hcl | 14 | $2,764 |
| Hydroxyurea | 31 | $630 |
| Dexamethasone | 11 | $186 |
| Anastrozole | 21 | $138 |
| Dexamethasone Sodium Phosphate | 33 | $127 |
| Prednisone | 22 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTagrisso | $392 | $1,713,525103 claims |
| E.r. Squibb & Sons, L.L.C.Opdivo | $66 | $206,09427 claims |
| MerckKeytruda | $355 | $191,01520 claims |
| Johnson & JohnsonProcrit | $546 | $115,67928 claims |
| PfizerRetacrit, Nivestym | $71 | $58,41631 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.
Other adult health in Brooklyn
- Huiwen YingBrooklyn$17K
- Joyce YeungBrooklyn$15K
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.